Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Oct 29, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 29
- −8 vs. Q2 2021
- Portfolio value
- $501.3M
- −$63.3M (−11.2%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRKMerck & Co., Inc. | Stock | 812,814 | $61.0M | 12.2% | +357,367+78.5% | Added | History |
| PFEPfizer Inc | Stock | 651,600 | $28.0M | 5.6% | −488,385−42.8% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 445,010 | $26.3M | 5.3% | −78,483−15.0% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 602,682 | $26.1M | 5.2% | +166,276+38.1% | Added | History |
| GILDGilead Sciences, Inc. | Stock | 371,085 | $25.9M | 5.2% | −206,283−35.7% | Reduced | History |
| CAHCardinal Health Inc | Stock | 523,606 | $25.9M | 5.2% | +154,675+41.9% | Added | History |
| BIIBBiogen Inc. | COM | 83,319 | $23.6M | 4.7% | +10,276+14.1% | Added | History |
| MDTMedtronic plc | Stock | 184,700 | $23.2M | 4.6% | −24,428−11.7% | Reduced | History |
| INCYIncyte Corp | COM | 302,739 | $20.8M | 4.2% | +18,594+6.5% | Added | History |
| BDXBecton Dickinson & Co | Stock | 81,593 | $20.1M | 4.0% | −13,088−13.8% | Reduced | History |
| BAXBaxter International Inc | Stock | 237,429 | $19.1M | 3.8% | +44,690+23.2% | Added | History |
| BRKRBruker Corp | COM | 233,252 | $18.2M | 3.6% | −73,398−23.9% | Reduced | History |
| OGNOrganon & Co. | Stock | 546,062 | $17.9M | 3.6% | −6,170−1.1% | Reduced | History |
| NUVANuvasive Inc | COM | 298,426 | $17.9M | 3.6% | +4,672+1.6% | Added | History |
| QGENQiagen N.V. | SHS NEW | 330,220 | $17.1M | 3.4% | +170,159+106.3% | Added | History |
| ELVElevance Health, Inc. | Stock | 43,192 | $16.1M | 3.2% | −1,432−3.2% | Reduced | History |
| CVSCVS Health Corp | Stock | 176,120 | $14.9M | 3.0% | −24,321−12.1% | Reduced | History |
| XRAYDentsply Sirona Inc. | Stock | 251,330 | $14.6M | 2.9% | +251,330 | New | History |
| CNCCentene Corp | Stock | 212,223 | $13.2M | 2.6% | −17,187−7.5% | Reduced | History |
| ELANElanco Animal Health Inc | COM | 409,731 | $13.1M | 2.6% | +13,253+3.3% | Added | History |
| LHLabcorp Holdings Inc. | COM NEW | 37,858 | $10.7M | 2.1% | −5,689−13.1% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 263,870 | $8.85M | 1.8% | +382+0.1% | Added | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 11,255 | $8.40M | 1.7% | −4,881−30.2% | Reduced | History |
| UHSUniversal Health Services Inc | CL B | 50,295 | $6.96M | 1.4% | +21,084+72.2% | Added | History |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 1,772,730 | $6.43M | 1.3% | +67,177+3.9% | Added | History |
| PDCOPatterson Companies, Inc. | COM | 170,547 | $5.14M | 1.0% | +28,804+20.3% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 110,767 | $4.91M | 1.0% | +20,029+22.1% | Added | History |
| MRTXMirati Therapeutics, Inc. | COM | 26,000 | $4.60M | 0.9% | +26,000 | New | History |
| NVAXNovavax Inc | COM NEW | 11,044 | $2.29M | 0.5% | −2,582−18.9% | Reduced | History |
Sold out since Q2 2021 (10)
Positions held at the end of Q2 2021 that are gone from this filing.
| Security | Class | Shares in Q2 2021 | Value in Q2 2021 | % of portfolio in Q2 2021 | History |
|---|---|---|---|---|---|
| HSICHenry Schein Inc | COM | 165,721 | $12.3M | 2.2% | History |
| RVTYRevvity, Inc. | COM | 67,661 | $10.4M | 1.9% | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 58,017 | $9.84M | 1.7% | History |
| PRGOPERRIGO Co plc | SHS | 204,732 | $9.39M | 1.7% | History |
| HOLXHologic Inc | COM | 117,738 | $7.86M | 1.4% | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 68,964 | $5.75M | 1.0% | History |
| JNJJohnson & Johnson | Stock | 30,000 | $4.94M | 0.9% | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 234,916 | $3.04M | 0.5% | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 4,876 | $2.72M | 0.5% | History |
| LIVNLivaNova PLC | SHS | 14,803 | $1.25M | 0.2% | History |